openPR Logo
Press release

Poised to Growth USD 476.58 Billion by 2032 with Thriving CAGR of 7.90%

07-16-2025 10:01 AM CET | Health & Medicine

Press release from: Market Research Future (MRFR)

Advanced Therapy Medicinal Products CDMO Market

Advanced Therapy Medicinal Products CDMO Market

AI-Driven Innovation and Biotech Partnerships Fuel Expansion of Advanced Therapy Medicinal Products (ATMPs) CDMO Market, Forecast to Surpass USD 117 Billion by 2034

The global Advanced Therapy Medicinal Products (ATMPs) Contract Development and Manufacturing Organization (CDMO) Market is on a sharp growth trajectory. According to industry analysis, the market was valued at USD 34.36 billion in 2025 and is projected to reach USD 117.52 billion by 2034, expanding at a CAGR of 14.64% during the forecast period.

This rapid expansion is driven by surging demand for personalized medicine, innovations in gene and cell therapy, and growing investment in biomanufacturing infrastructure. Notably, Google's advances in AI, machine learning, and cloud-based bioinformatics are enabling CDMOs to automate complex manufacturing processes, enhance data accuracy, and optimize therapy development timelines.

Request To Free Sample of This Strategic Report:

https://www.marketresearchfuture.com/sample_request/31150

Market Scope and Growth Drivers

ATMPs encompass gene therapy, cell therapy, and tissue engineering-therapeutic areas with immense potential to address chronic and rare diseases. CDMOs are critical players in bringing these therapies to market by offering development, manufacturing, and regulatory support services.

You Can Purchase Complete Report:

https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=31150

Key market drivers include:

Rising global prevalence of chronic and genetic disorders

Expanding pipeline of gene-edited and immune-modulating therapies

Increasing demand for integrated CDMO services from early development through to commercialization

Supportive government regulations and funding for regenerative medicine initiatives

Competitive Landscape

The ATMP CDMO space is highly competitive, with key players emphasizing capacity expansion, technology integration, and global reach.

Leading companies include:

Lonza

Samsung Biologics

Wuxi AppTec

MeiraGTx

Thermo Fisher Scientific

Catalent

Pfizer

Biogen

Bristol-Myers Squibb

Fujifilm

Cellectis

Amgen

AAV Gene Therapy Division (Emerging Segment)

These players are forming strategic partnerships with biotech startups, adopting AI-driven solutions for process efficiency, and scaling facilities to meet growing commercial production demands.

Browse In-depth Market Research Report (Pages, Charts, Tables, Figures):

https://www.marketresearchfuture.com/reports/advanced-therapy-medicinal-products-cdmo-market-31150

Technology Spotlight: Google's Role

Google Cloud and its Life Sciences division are reshaping how CDMOs approach data analytics, trial monitoring, and digital twin simulations. Applications of Google AI and Vertex AI in biomanufacturing are enabling:

Predictive process modeling for therapy scale-up

Automated quality control through computer vision

Genomic data management at cloud scale for gene therapy CDMOs

These technologies not only enhance manufacturing precision but also reduce cycle times and regulatory delays, giving CDMOs and pharma partners a significant time-to-market advantage.

Market Segmentation Insights

By Product Type

Gene Therapy: Projected to reach USD 10.5 billion by 2030 (CAGR: 22.5%)

Cell Therapy: Expected to grow to USD 20.0 billion by 2030 (CAGR: 25.0%)

Tissue Engineering: Estimated to hit USD 12.0 billion by 2030 (CAGR: 20.0%)

By Indication

Cancer: Dominant segment, forecasted at USD 35.2 billion by 2024

Immune Disorders: Rapid growth due to new immunotherapy applications

Cardiovascular and Neurological Disorders: Steady demand for advanced therapies

By Scale of Production

Clinical Trials: Fueled by early-phase therapy pipelines, valued at USD 6.5 billion by 2032

Commercial Production: Expanding due to therapy approvals, expected to reach USD 5.8 billion by 2032

By Service Type

Manufacturing: Leading segment (USD 11.87 billion in 2023)

Process Development: Fastest-growing (CAGR: 15.24%)

Regulatory Support: Critical as therapies face complex compliance pathways

Regional Market Analysis

North America: Leading market with advanced biotech infrastructure, strong R&D spending, and supportive FDA frameworks

Europe: Second-largest, driven by EU-wide ATMP regulations and rising investments in cell therapy hubs

Asia Pacific: Fastest-growing region due to supportive regulatory shifts, increasing local biomanufacturing capacity, and rising disease burden

South America & MEA: Emerging growth centers, with increased clinical trials and health system modernization

Recent Industry Developments

Lonza and Google Cloud announced an AI collaboration in 2025 to deploy real-time predictive maintenance and digital twin modeling in their ATMP facilities.

Samsung Biologics expanded its gene therapy CDMO suite with new GMP-grade viral vector capabilities.

Wuxi Advanced Therapies launched a new integrated CDMO platform enabling full end-to-end ATMP production.

Fujifilm Diosynth Biotechnologies opened a new North American ATMP site dedicated to personalized medicine manufacturing.

Outlook

With chronic diseases on the rise, new technologies like CRISPR reaching clinical maturity, and global infrastructure expanding, the ATMP CDMO market is set for unprecedented growth. As leading biotech and tech companies-including Google-continue to integrate AI and cloud platforms into therapy manufacturing, the ability to deliver scalable, personalized, and regulatory-compliant treatments is accelerating.

Related Reports :

Contract Research Organization (CRO) Market: https://www.marketresearchfuture.com/reports/contract-research-organization-market-3322

Hair Transplant Market: https://www.marketresearchfuture.com/reports/hair-transplant-market-3409

Preclinical CRO Market: https://www.marketresearchfuture.com/reports/preclinical-cro-market-7274

Electric Wheelchair Market: https://www.marketresearchfuture.com/reports/electric-wheelchair-market-6618

Wearable Medical Device Market: https://www.marketresearchfuture.com/reports/wearable-medical-device-market-899

Clinical Laboratory Test Market: https://www.marketresearchfuture.com/reports/clinical-laboratory-test-market-1649

Fertility Services Market: https://www.marketresearchfuture.com/reports/fertility-services-market-6281

Telemedicine Market: https://www.marketresearchfuture.com/reports/telemedicine-market-2216

Active Pharmaceutical Ingredients (API) Market: https://www.marketresearchfuture.com/reports/active-pharmaceutical-ingredients-market-1385

CAR T Cell Therapy Market: https://www.marketresearchfuture.com/reports/car-t-cell-therapy-market-8102

About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Poised to Growth USD 476.58 Billion by 2032 with Thriving CAGR of 7.90% here

News-ID: 4105926 • Views:

More Releases from Market Research Future (MRFR)

Payment Service Provider Market Projected to Hit USD 140.91 Billion at a 5.48% CAGR by 2034
Payment Service Provider Market Projected to Hit USD 140.91 Billion at a 5.48% C …
Market Overview: The Payment Service Provider (PSP) market has witnessed substantial growth over the past decade, driven by the explosive rise in digital commerce, mobile payments, and cross-border transactions. As businesses strive to streamline payment processes and deliver frictionless experiences to customers, the demand for robust, secure, and scalable PSP solutions has surged. PSPs serve as intermediaries between merchants and financial institutions, enabling the acceptance of electronic payments via multiple methods
Boundary Scan Hardware Market Poised for Growth, Reaching USD 3.16 Billion by 2034
Boundary Scan Hardware Market Poised for Growth, Reaching USD 3.16 Billion by 20 …
Market Overview: The Boundary Scan Hardware Market has emerged as a crucial segment within the electronics testing and debugging industry, offering advanced solutions for fault detection and circuit verification in integrated circuits (ICs) and printed circuit boards (PCBs). Leveraging the IEEE 1149.1 standard, boundary scan commonly referred to as JTAG (Joint Test Action Group) provides a non-invasive and efficient testing methodology that minimizes the need for physical probes. Boundary Scan Hardware
Metaverse for Automotive Market is Expected to Touch USD 123.51 Billion By 2034
Metaverse for Automotive Market is Expected to Touch USD 123.51 Billion By 2034
Market Overview: The Metaverse for Automotive Market is redefining how automakers, suppliers, and consumers interact in a digitally immersive world. With the integration of AR/VR, IoT, blockchain, and AI technologies, the automotive industry is stepping into the virtual realm to enhance everything from product design and manufacturing to marketing, sales, and customer service. The global rise in digital transformation, coupled with increasing consumer demand for interactive and customized experiences, is fueling
AGV Software Market to Grow at 10.82% CAGR, Hitting USD 6.46 Billion by 2034
AGV Software Market to Grow at 10.82% CAGR, Hitting USD 6.46 Billion by 2034
Market Overview: The AGV Software Market is rapidly evolving as industries shift towards intelligent automation and digital transformation in their logistics and material handling operations. AGV software acts as the brain of autonomous vehicles, enabling seamless navigation, scheduling, route optimization, fleet coordination, and task management. With the growing demand for efficient, contactless, and error-free logistics, AGV systems have found significant adoption across warehouses, manufacturing plants, ports, and healthcare facilities. AGV Software

All 5 Releases


More Releases for CDMO

Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Inhalation CDMO Market Size During the Forecast Period? In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size? The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications. The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for